pocketful logo light
pocketful logo light
Genpharmasec Ltd logo

Genpharmasec Ltd

NSE: BSE: 531592

1.16

(0%)

Thu, 28 May 2026, 04:43 am

Genpharmasec Share Price Live Chart

1 Day

(0%)

No Result Found

Summary

  • Market Cap

    69.21

  • Net Profit

    1.23

  • P/B

    1.60

  • Sector P/E

    59.64

  • P/E

    94.50

  • EV/EBITDA

    33.34

  • Debt/Equity (Industry)

    0.52

  • Interest Cover (Industry)

    40.83

  • ROCE (Industry)

    0.01

  • RONW (Industry)

    0.01

  • ROE

    1.85

  • ROCE

    3.28

  • Debt/Equity

    0.07

  • EPS (TTM)

    0.03

  • Dividend Yield

    0

  • Book Value

    1.20

  • Interest Cover

    5.18

Analysis

all

thumbs up icon

Pros

  • Generic Pharmasec is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Generic Pharmasec is profitable, therefore cash runway is not a concern.
  • Generic Pharmasec is profitable, therefore cash runway is not a concern.
  • Generic Pharmasec has no debt, it does not need to be covered by operating cash flow.
  • Generic Pharmasec has no debt, it does not need to be covered by short term assets.
thumbs up icon

Cons

  • Unable to evaluate Generic Pharmasec's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Generic Pharmasec's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • The average tenure for the Generic Pharmasec board of directors is less than 3 years, this suggests a new board.
  • Generic Pharmasec is not covered by any analysts.
  • Generic Pharmasec has significant price volatility in the past 3 months.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters29.9829.9829.9829.9829.98
FII00000
DII00000
Public70.0270.0270.0270.0270.02
Government00000

Read More

Technical Analysis

RSI

55.74

MACD

0.02

50 DMA

1.14

200 DMA

1.46

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2.201.661.441.120.900.580.04
Fibonacci1.661.451.331.120.910.790.58
Camarilla1.371.321.271.121.171.121.07

Pivots Level: Classic

R3

+1.08

2.20

R2

+0.54

1.66

R1

+0.32

1.44

1.12
1.12
Pivot Point
LTP: 1.25

S1

-0.22

0.90

S2

-0.54

0.58

S3

-1.08

0.04

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1.23

  • 20-EMA

    1.21

  • 30-EMA

    1.20

  • 50-EMA

    1.19

  • 100-EMA

    1.25

  • 200-EMA

    1.45

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
21 May 2026board-meetingsAccounts, Quarterly Results
09 Feb 2026board-meetingsQuarterly Results
06 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
02 Sept 2025agm
27 Jun 2024agm
03 Jan 2024rights1:1 Rights Issue of Equity Shares09 Jan 2024
09 Dec 2023rightsRight Issue of Equity Shares09 Jan 2024
31 Aug 2023agm
08 May 2023egm
21 Sept 2022agm

Read More

Peer Comparison

Genpharmasec Ltd logo

Genpharmasec Ltd

Premier Energies Ltd logo

Premier Energies Ltd

Adani Enterprises Ltd logo

Adani Enterprises Ltd

Redington Ltd logo

Redington Ltd

Aegis Logistics Ltd logo

Aegis Logistics Ltd

Honasa Consumer Ltd logo

Honasa Consumer Ltd

Read More

Genpharmasec Ltd About

Genpharmasec is dealing primarily in pharmaceutical activities / services and trading in equity shares.

Industry

Trading

Founded

1992

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.genpharmasec.com

Email icon

Email

info@genpharmasec.com; compliance@genpharmasec.com

Phone icon

Phone

Location icon

Location

Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East), Mumbai, Maharashtra, 400101

Read More

Genpharmasec Ltd Company History

YearHistory
2011
  • Registered Office of the Company has been shifted to 23, Sarvopari Mall, Opp. Utsav Party Plot, Sola Road, Ahmedabad - 380063.
2014
  • Company has shifted its registered office from 23, Sarvopari Mall, Opp. Utsav Party Plot, Sola Road, Ahmedabad - 380063 to GF-64, Block I, Titanium City Center, Nr. Sachin Tower, 100 Ft Road, Satellite, Ahmedabad - 380015.
2019
  • The Company has split its face value from Rs. 10/- to Rs. 1/-
  • Company name has changed to Generic Pharmasec Ltd. from Adi Rasayan Ltd.
2023
  • Company name has changed to Genpharmasec Ltd. from Generic Pharmasec Ltd.
2024
  • The company issued rights shares of Rs. 1 in the ratio of 1:1 at a premium of Rs. 0.75 per share.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
DIVYA DEVEN PATHAKbulkSell35000002.9530 Dec 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell28575813.3104 Sept 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkBuy30576933.1803 Sept 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell9311493.2703 Sept 2024
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkBuy34000033.7830 Aug 2024
ISHAAN TRADEFIN LLPbulkBuy45000003.7130 Aug 2024
ISHAAN TRADEFIN LLPbulkSell45000003.8730 Aug 2024
STALLION WEALTH MANAGEMENT LLPbulkBuy60500003.3627 Aug 2024
ISHAAN TRADEFIN LLPbulkSell40000003.3627 Aug 2024
ISHAAN TRADEFIN LLPbulkBuy40000003.2227 Aug 2024

Read More

Genpharmasec Ltd News

Genpharmasec FY26 Net Profit at ₹544.96 Cr

Genpharmasec Limited reported a net profit of ₹544.96 lakh for the year ended March 31, 2026. Revenue from operations stood at ₹13,134.94 lakh.

21 May 2026

companies

Genpharmasec Board Meeting Set for May 21, 2026

Genpharmasec Limited schedules a Board of Directors meeting on May 21, 2026, to consider audited standalone and consolidated financial results for Q4 and FY26.

13 May 2026

companies

Genpharmasec declares non-applicability of LC framework

Genpharmasec Limited confirms it doesn't fall under Large Corporate category as per SEBI circulars, exempting it from related debt securities disclosure requirements.

14 Apr 2026

companies

Genpharmasec Files Q4 FY26 Demat Certificate

Genpharmasec Limited submits quarterly certificate under SEBI regulations for Q4 FY26, confirming no physical share certificates received for dematerialization during the quarter ended March 31, 2026.

08 Apr 2026

companies

Genpharmasec Independent Directors Meet on March 24

Genpharmasec Limited's independent directors conducted their separate meeting on March 24, 2026, reviewing board performance and information flow as per regulatory requirements.

24 Mar 2026

companies

Read More